In a meeting on Wednesday, February 4, 2026, Metropolis Healthcare announced that the Board of Directors had approved and recommended the issuance of bonus equity shares in the ratio of 3:1, or three fully paid-up equity shares with a face value of Rs 2/-each for every one fully paid-up equity share with a face value of Rs 2/-each held by the members on the record date, subject to members, statutory, and regulatory approvals, as applicable.
“The record date for determining the entitlement of the members of the Company to receive bonus equity shares will be announced in due course,” said Metropolis Healthcare in a statement.
The company has proposed the issuance of 15,54,95,826 bonus equity shares of face value Rs 2 each, aggregating to a total amount of approximately Rs 31.09 crore.
In keeping with the company’s goal of rewarding shareholders and enhancing stock liquidity, these bonus shares will be issued to eligible shareholders without any cash consideration.
The company’s free reserves, namely the Securities Premium Account, General Reserve, and/or Retained Earnings, as shown in the audited financial accounts for the fiscal year that ended on March 31, 2025, would be used to fund the bonus issue.
The company has announced a bonus ratio of 3:1, meaning shareholders will receive three fully paid-up equity shares of Rs 2 each for every one fully paid-up equity share held as on the record date. All bonus shares will rank pari passu with existing equity shares in all respects, including dividend and voting rights.
Prior to the bonus issue, the authorized share capital was Rs 63.86 crore, which was divided into 31,93,04,015 equity shares, each worth Rs 2. A total of 5,18,31,942 equity shares worth Rs 2 each made up the issued, subscribed, and paid-up share capital of Rs 10.36 crore. Following the bonus issue, the issued, subscribed, and paid-up share capital increased to Rs 41.46 crore, divided into 20,73,27,768 equity shares of Rs 2 each, while the authorized share capital stayed at Rs 63.86 crore.
The corporation needs about Rs 31.09 crore in reserves to implement the bonus issue. The company has enough reserves to fund the bonus issue, according to the most recent audited financial records as of March 31, 2025. These reserves include Securities Premium of Rs 24,926.52 lakh, General Reserve of Rs 2,987.38 lakh, and Retained Earnings of Rs 94,702.25 lakh.
The estimated date by which such bonus shares would be credited/dispatched is on or before April 03, 2026 as per Metropolis Healthcare.
The company’s consolidated profit after tax increased 33.7% YoY to Rs 42 crore in Q3FY26 from Rs 31 crore in Q3FY25. Compared to Rs 323 crore in Q3FY25, revenue from operations climbed 25.8% YoY to Rs 406 crore in Q3FY26. EBITDA jumped 32.4% YoY from Rs 72 crore in Q3FY25 to Rs 95 crore in Q3FY26. The EBITDA margin improved by 120 basis points to 23.4% in Q3FY26 from 22.2% in the same period last year.
Metropolis Healthcare Target Price
“Metropolis Healthcare stock price is slightly bullish on the Daily charts with strong support at 1835. A Daily close above resistance of 1975 could lead to a target of 2100 in the near term,” commented A R Ramachandran, part-time SEBI-registered Research Analyst, Tips2trades.
Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as “we”). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.
